Dingdang Health Technology Group Ltd. reported a small-scale on-market share repurchase on 1 September 2026, acquiring 34,000 ordinary shares at HK$0.865 each. The transaction cost HK$29,410 and the repurchased shares have been retained as treasury stock.
Following the buyback, Dingdang Health’s outstanding share count (excluding treasury shares) declined by 0.0027 percentage points to 1.24 billion shares, while treasury shares increased to 1.23 million. The company’s total issued share capital remains unchanged at 1.24 billion shares.
The repurchase forms part of a broader mandate granted on 23 June 2026 that authorises the company to repurchase up to 124.32 million shares. Cumulative repurchases under this mandate now stand at 4.09 million shares, equivalent to 0.33% of the issued share base on the authorisation date.
In line with Hong Kong Exchange rules, Dingdang Health is subject to a moratorium on issuing, selling or transferring any shares or treasury shares until 1 October 2026.
Comments